Announcement no. 33/2025 Interim report Q2 2025 22 July 2025 COPENHAGEN, Denmark, July 22, 2025 /PRNewswire/ -- Sveinn Sölvason, President and CEO, comments: "Sales in Q2 2025 amounted to USD 232 million, representing 7% reported growth, of which 5% was organic. Growth was strong in the...
Hence then, the article about embla medical hf interim report q2 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Embla Medical hf: Interim Report Q2 2025 )
Also on site :
- Best ERP Solutions for Manufacturing (2026): Sage Named UK's Top Choice for Operations and Inventory Management by Expert Consumers
- Samduo lanceert Nex Series op Solar Solutions International 2026 en bevordert energieonafhankelijkheid van huishoudens in heel Europa
- White House takes first step toward permanent fix for illegal tariffs